$HSTM
HealthStream Inc

2017 Q1 Form 10-Q Financial Statement

#000119312517151764 Filed on May 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $51.97M $54.08M
YoY Change -3.9% 14.68%
Cost Of Revenue $21.15M $22.90M
YoY Change -7.63% 13.41%
Gross Profit $30.82M $31.18M
YoY Change -1.16% 15.63%
Gross Profit Margin 59.3% 57.65%
Selling, General & Admin $16.77M $16.53M
YoY Change 1.45% 15.8%
% of Gross Profit 54.42% 53.02%
Research & Development $5.775M $7.018M
YoY Change -17.71% 51.05%
% of Gross Profit 18.74% 22.51%
Depreciation & Amortization $5.902M $5.140M
YoY Change 14.82% 58.01%
% of Gross Profit 19.15% 16.49%
Operating Expenses $5.775M $7.018M
YoY Change -17.71% -62.91%
Operating Profit $2.365M $2.487M
YoY Change -4.91% -48.08%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $130.0K $18.00K
YoY Change 622.22% 100.0%
Pretax Income $2.495M $2.505M
YoY Change -0.4% -47.8%
Income Tax $786.0K $1.004M
% Of Pretax Income 31.5% 40.08%
Net Earnings $1.285M $1.501M
YoY Change -14.39% -44.86%
Net Earnings / Revenue 2.47% 2.78%
Basic Earnings Per Share $0.04 $0.05
Diluted Earnings Per Share $0.04 $0.05
COMMON SHARES
Basic Shares Outstanding 31.77M shares 31.67M shares
Diluted Shares Outstanding 32.10M shares 31.97M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.3M $150.5M
YoY Change -23.39% 133.7%
Cash & Equivalents $53.03M $82.79M
Short-Term Investments $62.30M $67.70M
Other Short-Term Assets $7.965M $6.371M
YoY Change 25.02% 10.22%
Inventory
Prepaid Expenses
Receivables $39.27M $32.39M
Other Receivables $0.00 $0.00
Total Short-Term Assets $184.0M $205.7M
YoY Change -10.54% 64.93%
LONG-TERM ASSETS
Property, Plant & Equipment $10.49M $12.17M
YoY Change -13.77% 12.45%
Goodwill $109.8M $85.25M
YoY Change 28.75% -3.96%
Intangibles
YoY Change
Long-Term Investments $3.300M $3.600M
YoY Change -8.33% 28.57%
Other Assets $645.0K $612.0K
YoY Change 5.39% -73.56%
Total Long-Term Assets $217.8M $170.1M
YoY Change 28.06% -2.65%
TOTAL ASSETS
Total Short-Term Assets $184.0M $205.7M
Total Long-Term Assets $217.8M $170.1M
Total Assets $401.8M $375.8M
YoY Change 6.93% 25.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.837M $1.385M
YoY Change 177.04% -27.26%
Accrued Expenses $7.656M $8.731M
YoY Change -12.31% -10.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $98.13M $83.63M
YoY Change 17.33% -5.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.590M $1.060M
YoY Change 50.0% -60.61%
Total Long-Term Liabilities $1.590M $1.060M
YoY Change 50.0% -96.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $98.13M $83.63M
Total Long-Term Liabilities $1.590M $1.060M
Total Liabilities $99.72M $84.69M
YoY Change 17.74% -28.83%
SHAREHOLDERS EQUITY
Retained Earnings $8.823M $3.092M
YoY Change 185.35% -171.77%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $289.8M $282.1M
YoY Change
Total Liabilities & Shareholders Equity $401.8M $375.8M
YoY Change 6.93% 25.5%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $1.285M $1.501M
YoY Change -14.39% -44.86%
Depreciation, Depletion And Amortization $5.902M $5.140M
YoY Change 14.82% 58.01%
Cash From Operating Activities $16.53M $5.710M
YoY Change 189.44% -36.63%
INVESTING ACTIVITIES
Capital Expenditures $931.0K $2.685M
YoY Change -65.33% 16.08%
Acquisitions
YoY Change
Other Investing Activities -$9.510M -$20.00K
YoY Change 47450.0% -99.97%
Cash From Investing Activities -$12.86M -$4.700M
YoY Change 173.6% -94.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -268.0K -230.0K
YoY Change 16.52% -100.82%
NET CHANGE
Cash From Operating Activities 16.53M 5.710M
Cash From Investing Activities -12.86M -4.700M
Cash From Financing Activities -268.0K -230.0K
Net Change In Cash 3.400M 780.0K
YoY Change 335.9% -101.65%
FREE CASH FLOW
Cash From Operating Activities $16.53M $5.710M
Capital Expenditures $931.0K $2.685M
Free Cash Flow $15.60M $3.025M
YoY Change 415.57% -54.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31882227 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82793000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2192000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31840000 shares
CY2017Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
280986000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31840000 shares
CY2017Q1 us-gaap Assets
Assets
401824000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
184034000
CY2017Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
12137000
CY2017Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
17652000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
956000
CY2017Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
62265000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53034000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39267000
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7790000
CY2017Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
2192000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3837000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
72306000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000
CY2017Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
34045000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4556000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7656000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18846000
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
7965000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
401824000
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75963000
CY2017Q1 us-gaap Goodwill
Goodwill
109765000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1590000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
98128000
CY2017Q1 us-gaap Prepaid Royalties
PrepaidRoyalties
18613000
CY2017Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3271000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
645000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10494000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
289760000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8823000
CY2017Q1 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2890000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82010000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1994000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31748000 shares
CY2016Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
280813000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31748000 shares
CY2016Q4 us-gaap Assets
Assets
396000000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
177437000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
13161000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16310000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
863000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
53540000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49634000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44805000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7859000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3127000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68542000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51000
CY2016Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
31787000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5968000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8146000
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16445000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8694000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
396000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
78364000
CY2016Q4 us-gaap Goodwill
Goodwill
109765000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1095000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94970000
CY2016Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
18183000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3276000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
603000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10245000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
286108000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5346000
CY2016Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2581000
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
143000 shares
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001095565
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
441000
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3400000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441000
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
26276000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6387000
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1287000
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
58037000
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.345 pure
CY2017Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
57000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
526000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
59870000
CY2017Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7941000
CY2017Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
430000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-276000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
1285000
CY2017Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
28211000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1963000
CY2017Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5028000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12859000
CY2017Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-147000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-730000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
42000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
330000 shares
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1833000
CY2017Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1024000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-268000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3696000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
367000
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
678000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16527000
CY2017Q1 us-gaap Payments For Software
PaymentsForSoftware
2970000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1018000
CY2017Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
148000
CY2017Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-268000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32104000 shares
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19340000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31774000 shares
CY2017Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
0 shares
CY2017Q1 dei Trading Symbol
TradingSymbol
HSTM
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6599000
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
99000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10834000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-789000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-314000
CY2017Q1 hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3 Incentive_Plan
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85000 shares
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
783000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2016Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22900000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5140000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1557000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
51591000
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.401 pure
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
54078000
CY2016Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7976000
CY2016Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
1027000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2099000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1501000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41912000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
90000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2505000
CY2016Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4451000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4696000
CY2016Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
56000
CY2016Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
975000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1879000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
304000 shares
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2487000
CY2016Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
768000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-233000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3218000
CY2016Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
288000
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1004000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5712000
CY2016Q1 us-gaap Payments For Software
PaymentsForSoftware
1990000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2685000
CY2016Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
339000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31970000 shares
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
40916000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31666000 shares
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7018000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
55000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8557000

Files In Submission

Name View Source Status
0001193125-17-151764-index-headers.html Edgar Link pending
0001193125-17-151764-index.html Edgar Link pending
0001193125-17-151764.txt Edgar Link pending
0001193125-17-151764-xbrl.zip Edgar Link pending
d371755d10q.htm Edgar Link pending
d371755dex101.htm Edgar Link pending
d371755dex102.htm Edgar Link pending
d371755dex311.htm Edgar Link pending
d371755dex312.htm Edgar Link pending
d371755dex321.htm Edgar Link pending
d371755dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-20170331.xml Edgar Link completed
hstm-20170331.xsd Edgar Link pending
hstm-20170331_cal.xml Edgar Link unprocessable
hstm-20170331_def.xml Edgar Link unprocessable
hstm-20170331_lab.xml Edgar Link unprocessable
hstm-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending